期刊文献+

P2Y12基因单核苷酸多态性与冠心病的相关性研究 被引量:1

Correlation analysis between P2Y12 gene single nucleotide polymorphisms and coronary heart disease
下载PDF
导出
摘要 目的探讨血小板二磷酸腺苷(adenosine diphosphate,ADP)受体亚基12(P2Y12)基因单核苷酸多态性位点rs2046934、rs6787801、rs6798347及rs6801273与冠状动脉粥样硬化性心脏病(冠心病)发生的相关性。方法入选455例冠心病患者和90例健康对照。所有冠心病患者均行冠状动脉造影检查或冠状动脉计算机断层扫描血管造影确诊冠心病。应用Mass ARRAY时间飞行质谱技术对P2Y12基因的单核苷酸多态性位点进行基因分型。比较两组在基因型分布及等位基因频率上的差别。结果冠心病组与对照组在rs2046934位点的基因型分布(CC:2.4%vs.4.4%、TT:71.0%vs.74.4%、CT:26.6%vs.21.2%)和等位基因频率(C等位基因:15.7%vs.15.0%、T等位基因:84.3%vs.85.0%)比较,差异无统计学意义(P>0.05)。两组rs6787801位点的基因型分布(GG:17.4%vs.17.8%、AA:36.9%vs.31.3%、GA:45.7%vs.51.1%)和等位基因频率(G等位基因:40.2%vs.43.3%、A等位基因:59.8%vs.56.7%)比较,差异无统计学意义(P>0.05)。两组rs6798347位点的基因型分布(AA:9.1%vs.6.7%、GG:41.6%vs.52.2%、AG:49.3%vs.41.1%)和等位基因频率(A等位基因:29.9%vs.27.2%、G等位基因:70.1%vs.72.8%)比较,差异无统计学意义(P>0.05)。两组rs6801273位点的基因型分布(CC:13.4%vs.10.0%、TT:42.6%vs.50.0%、CT:44.0%vs.40.0%)和等位基因频率(C等位基因:35.4%vs.30.0%、T等位基因:64.6%vs.70.0%)比较,差异无统计学意义(P>0.05)。结论 P2Y12基因单核苷酸多态性位点(rs2046934、rs6787801、rs6798347及rs6801273)与冠心病发生无相关性。 Objectives To investigate the correlation between platelet adenosine diphosphate acceptor subunit 12(P2Y12) gene polymorphisms(rs2046934, rs6787801, rs6798347 and rs6801273) and coronary heart disease.Methods Totally 455 patients with coronary artery disease who were diagnosed by coronary angiography or coronary artery computed tomography angiography and 90 healthy control individuals were enrolled in this study. The single nucleotide polymorphisms(rs2046934, rs6787801, rs6798347 and rs6801273) of P2Y12 gene were detected by Mass ARRAY Time of Flight Mass Spectrometry. The genotypes and allele frequencies between the two groups were compared. Results Genotypes and frequencies of P2Y12 gene polymorphisms rs2046934 in coronary heart disease group and control group were as below : CC genotype 2.4% vs. 4.4%, TT genotype 71.0% vs. 74.4%, CT genotype26.6% vs. 21.2%; and C allele frequencies were 15.7% vs. 15.0%, T allele frequencies were 84.3% vs. 85.0%.There were no significant differences between the two groups(P〉0.05). As for gene polymorphisms rs6787801, GG genotype was 17.4% vs. 17.8%, AA genotype 36.9% vs. 31.3%, GA genotype 45.7% vs. 51.1%; and G allele frequencies were 40.2% vs. 43.3%, A allele frequencies were 59.8% vs. 56.7%. There were no significant differences in genotypes and frequencies of P2Y12 gene polymorphisms rs6787801 between these two groups(P〉0.05). As for gene polymorphisms rs6798347, AA genotype was 9.1% vs. 6.7%, GG genotype 41.6% vs. 52.2%, AG genotype 49.3%vs. 41.1%; and A allele frequencies were 29.9% vs. 27.2%, G allele frequencies were 70.1% vs. 72.8%. There were no significant differences in genotypes and frequencies of P2Y12 gene polymorphisms rs6798347 between these two groups(P〉0.05). As for gene polymorphisms rs6801273, CC genotype was 13.4% vs. 10.0%, TT genotype 42.6% vs.50.0%, CT genotype 44.0% vs. 40.0%; and C allele frequencies were 35.4% vs. 30.0%, T allele frequencies were64.6% vs. 70.0%. There were no significant differences in genotypes and frequencies of P2Y12 gene polymorphisms rs6801273 between these two groups(P〈0.05). Conclusions Single nucleotide polymorphisms of P2Y12 gene in rs2046934, rs6787801, rs6798347 and rs6801273 are not associated with coronary heart disease.
出处 《岭南心血管病杂志》 2015年第2期163-166,248,共5页 South China Journal of Cardiovascular Diseases
关键词 冠状动脉疾病 血小板二磷酸腺苷受体亚基12 多态性 单核苷酸 coronary heart disease platelet adenosine diphosphate acceptor subunit 12 polymorphism single nucleotide
  • 相关文献

参考文献9

  • 1ROSS R. Atherosclerosis : an inflammatory disease [ J ]. N Engl J Med, 1999, 340(2) : 115-126.
  • 2CAPRIE Steering Committee. A randomised, blinded, trial of Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE) [C]. Lancet, 1996, 348 (9038) : 1329- 1339.
  • 3FONTANA P, GAUSSEM P, AIACH M, et al. P2Y12 H2 Haplotype is associated with peripheral arterial disease: a case-control study [J]. Circulation, 2003, 108 (24) :2971 - 2973.
  • 4陈碧莲,李清,解勤之,谢伟,马琦琳.P2Y_(12)受体基因多态性在中国人群中的分布和对氯吡格雷疗效的影响[J].中国新药杂志,2008,17(16):1435-1439. 被引量:10
  • 5孟影,王邦宁,周炳凤,胡泽平.冠心病侧支循环与肝细胞生长因子的表达及其基因C57488A多态性的关系[J].实用医学杂志,2013,29(21):3514-3517. 被引量:2
  • 6HOLLOPETER G, JANTZEN H M, VINCENT D, et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs [ J ]. Nature, 2001, 409 (6817 ) : 202-207.
  • 7UGO C, EL1SABETTA T, GIOVANNI M, et al. Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease [J]. BMC Medical Genetics, 2007, 8 ( 1 ) : 59-65.
  • 8BOUMAN H J, VAN WERKUM J W, RUDEZ G, et al. The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor [J]. Thromb Haemost, 2010, 103(2): 379-386.
  • 9RUDEZ G, BOUMAN H J, VAN WERKUM J W, et al. Common variation in the platelet receptor P2RY12 gene is associated witit residual ou-elopidogrei platelet reactivity iu patients undergoing elective percutaaeous coronary interventions [J]. Cire Cardiovasc Genet, 2009, 2(5) : 515-521.

二级参考文献28

  • 1FONTANA P, DUPONT A, GANDRILLE S, et al. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects [ J ]. Circulation,2003, 108(8):989 -995.
  • 2MEHTA SR, YUSUF S, PETERS RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study[J]. Lancet, 2000, 358(9281):527 -533.
  • 3YUSUF S, ZHAO F, MEHTA SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-elevation[ J ]. N Engl J Med , 2001, 345 (7) :494 -502
  • 4NGUYEN TA, DIODATI JG, PHARAND C. Resistance to clopidogrel : a review of the evidence[ J]. J Am Coll Cardiol, 2005, 45(8) :1157 -1164.
  • 5VON BECKERATH N, VON BECKERATH O, KOCH W, et al. P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphate-induced platelet aggregation after initiation of clopidogrel therapy with a high loading dose [ J ]. Blood Coagul Fibrinolysis, 2005, 16 ( 3 ) : 199 - 204.
  • 6ANGIOLILLO DJ, FERNANDEZ-ORTIZ A, BERNARDO E, et al. Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease[J]. Thromb Res, 2005, 116(6) :491 -497.
  • 7BLIN N, STAFFORD DW. A general method for isolation of high molecular weight DNA from eukaryotes [ J ]. Nucleic Acids Res, 1976, 3(9) :2303 -2308.
  • 8LAU WC, GURBEL PA, WATKINS PB, et al. Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance [ J ]. Circulation, 2004, 109 ( 2 ) :166 -171.
  • 9TAUBERT D, VON BECKERATH N, GRIMBERG G, et al. Impact of P-glycoprotein on clopidogrel absorption [ J ]. Clin Pharmacol Ther, 2006, 80(5 ):486-501.
  • 10TAUBERT D, KASTRATI A, HARLFINGER S, et al. Pharmacokinetics of clopidogrel after administration of high loading dose [J]. Thromb Haemost, 2004, 92(2) :311 -316.

共引文献10

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部